Supplementary Figure 1 from Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) trial in acquired PARP-inhibitor-resistant homologous recombination deficient ovarian cancer
作者
Stephanie L. Wethington,Payal D. Shah,Lainie P. Martin,János L. Tanyi,Nawar Latif,Mark A. Morgan,Drew A. Torigian,Diego Rodriguez,Simon A. Smith,Emma Dean,Susan M. Domchek,Ronny Drapkin,Ie‐Ming Shih,Eric J. Brown,Wei‐Ting Hwang,Deborah K. Armstrong,Stéphanie Gaillard,Robert Giuntoli,Fiona Simpkins
PDF的下载单位、IP信息已删除
(2025-6-4)
GingerF
愉快的真
wenhui
你嵙这个期刊没买
v0id
嘻嘻哈哈
yiiy
大力的冬萱
能帮就帮
Kao
HFH
369ninja
完美巧凡
谦让的洋葱
归零者
22336
prigogin
南柯
猪猪hero
淡定荧
皖公网安备34019202002308
